---
document_datetime: 2023-09-21 17:26:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/strimvelis-epar-all-authorised-presentations_en.pdf
document_name: strimvelis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6994581
conversion_datetime: 2025-12-18 23:12:38.199027
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | Invented name   | Strength              | Pharmaceutical Form     | Route of Administration   | Immediate Packaging   | Content (concentration)          | Pack size                                            |
|------------------|-----------------|-----------------------|-------------------------|---------------------------|-----------------------|----------------------------------|------------------------------------------------------|
| EU/1/16/1097/001 | Strimvelis      | 1-10 million cells/ml | Dispersion for infusion | Intravenous use           | bag (EVA)             | Patient specific up to 50 ml max | 1 or more bags each with 1 luer spike interconnector |